Heads UP Episode 110 - New Data: Topiramate vs. Erenumab

News
Written By

The HER-MES trial is a newly published study comparing the tolerability and efficacy of topiramate (Topamax) and erenumab (Aimovig). The results of this trial could impact prescribing practices and payor policies. Tune in this afternoon for this episode of Heads UP as Lindsay Weitzel, Ph.D. and Tim Smith, MD discuss the important aspects of the HER-MES trial.

Previous

Heads UP Episode 111: Low Pressure Headache and Finding the Leak
Next

Heads UP Episode 109 - New Data Alert on Intranasal Zavegepant